Last updated: March 2026
TUDCA (tauroursodeoxycholic acid) is a naturally occurring bile acid that protects the liver by reducing endoplasmic reticulum stress, displacing toxic bile acids, and stabilizing mitochondria. Widely used as liver support alongside oral anabolic steroids, SARMs, and other hepatotoxic compounds — and increasingly studied as a neuroprotectant.
TUDCA works through multiple overlapping mechanisms — it's not a single-target compound. Its primary actions protect hepatocytes and neurons from several independent stress pathways simultaneously.
The endoplasmic reticulum (ER) is the cell's protein-folding factory. When overwhelmed (by toxins, high fat intake, or oxidative stress), the unfolded protein response (UPR) triggers apoptosis. TUDCA acts as a chemical chaperone — it stabilizes misfolded proteins and suppresses UPR signaling, directly preventing ER-stress-induced cell death in hepatocytes and neurons.
Toxic hydrophobic bile acids (like lithocholic acid and deoxycholic acid) accumulate in the liver during cholestasis and oral steroid use. These disrupt cell membranes and cause hepatocyte death. TUDCA is water-soluble (hydrophilic) and displaces these toxic bile acids in the bile acid pool, making bile less damaging. This is its primary mechanism in cholestatic liver disease.
TUDCA prevents the mitochondrial permeability transition pore (mPTP) from opening — a key event in apoptotic cell death. By stabilizing the outer mitochondrial membrane, TUDCA preserves ATP production and blocks the cytochrome-c release that triggers caspase cascades. This mechanism is particularly relevant for protecting neurons in ALS and Parkinson's research.
TUDCA crosses the blood-brain barrier and exerts neuroprotective effects via the same ER stress and mitochondrial pathways. Preclinical studies show it slows neurodegeneration in models of ALS, Parkinson's, Huntington's, and retinal degeneration. A Phase 2 ALS trial showed modest slowing of functional decline (~20% slower on ALSFRS-R), though results were mixed across cohorts.
Clinical and preclinical data on TUDCA's hepatoprotective and neuroprotective effects.
Liver support and monitoring products for TUDCA users.
Dosing schedules, interaction warnings, and cycle protocols for 50+ compounds — all in one place.
This page is for educational purposes only. It is not medical advice. TUDCA is sold as a dietary supplement but has not been evaluated by the FDA for treating liver disease or protecting against steroid-induced hepatotoxicity. Always consult a qualified physician before using TUDCA, especially if you have pre-existing liver conditions or are taking other medications.